clinical trial · NCT05028140
Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
EMS·phase3·recruiting·n = 480
Type II DiabetesPIEMONTEPIEMONTE PLACEBOEMPAGLIFLOZINPLACEBO EMPAGLIFLOZINPIOGLITAZONEPLACEBO PIOGLITAZONE
brief summary
The purpose of this study is to evaluate the efficacy and safety of Piemonte association in the treatment of type 2 diabetes mellitus
started
Oct 8, 2024
primary completion
Jul 1, 2026
completion
Sep 1, 2027
last updated
Dec 8, 2025
official title
National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol